About this trial
Arthroscopic shoulder surgery is associated with moderate to severe postoperative pain that may delay recovery and rehabilitation. Interscalene brachial plexus block (ISB) is widely used for postoperative analgesia in shoulder surgery; however, it may be associated with complications such as phrenic nerve paralysis. The serratus posterior superior intercostal plane (SPSIP) block is a recently described fascial plane block that may provide effective analgesia while avoiding some of the limitations of ISB.
This prospective, randomized, double-blind controlled trial aims to compare the analgesic efficacy of ISB and SPSIP block in patients undergoing elective arthroscopic shoulder surgery under general anesthesia. The primary outcome is total postoperative opioid consumption during the first 24 hours after surgery. Secondary outcomes include postoperative pain scores, quality of recovery, time to first rescue analgesia, rescue analgesic requirements, intraoperative opioid consumption, sensory block distribution, motor block characteristics, and block-related complications.
Eligibility criteria
Qualifiers
Age between 18 and 75 years
ASA physical status I, II, or III
Scheduled for elective arthroscopic shoulder surgery under general anesthesia
Provision of written informed consent
Disqualifiers
Refusal to participate in the study
Coagulopathy
Current anticoagulant therapy
Infection at the block site
Trial design
Treatments tested in this trial
- Interscalene Brachial Plexus Block
- Serratus Posterior Superior Intercostal Plane Block
- Bupivacaine
Treatment groups
Sponsors and collaborators
Ferit Yetik
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Sponsor institution
Bursa Sehir Hastanesi
Collaborator